scholarly journals Measuring outcomes in ultra-rare bone diseases: Methodology of the palovarotene fibrodysplasia ossificans progressiva clinical development programme

Bone Reports ◽  
2020 ◽  
Vol 13 ◽  
pp. 100609
Author(s):  
Robert J. Pignolo ◽  
Geneviève Baujat ◽  
Matthew A. Brown ◽  
Carmen De Cunto ◽  
Maja Di Rocco ◽  
...  
2021 ◽  
Vol 10 (3) ◽  
Author(s):  
Jordis Trischler ◽  
Ivan Bottoli ◽  
Reinhold Janocha ◽  
Christoph Heusser ◽  
Xavier Jaumont ◽  
...  

Digestion ◽  
1990 ◽  
Vol 47 (1) ◽  
pp. 54-58 ◽  
Author(s):  
A. Walan

2020 ◽  
Vol 23 (1) ◽  
pp. 1-20 ◽  
Author(s):  
E. Michael Lewiecki ◽  
John P. Bilezikian ◽  
Risa Kagan ◽  
Deborah Krakow ◽  
Michael R. McClung ◽  
...  

2020 ◽  
Vol 15 (1) ◽  
Author(s):  
E. Brizola ◽  
G. Adami ◽  
G. I. Baroncelli ◽  
M. F. Bedeschi ◽  
P. Berardi ◽  
...  

Haemophilia ◽  
2013 ◽  
Vol 20 ◽  
pp. 1-9 ◽  
Author(s):  
L. A. Valentino ◽  
C. Negrier ◽  
G. Kohla ◽  
A. Tiede ◽  
R. Liesner ◽  
...  

2021 ◽  
Vol 3 (1) ◽  
pp. 01-03
Author(s):  
Prabir Mandal ◽  
Noor Islam ◽  
Anita Mandal

The human skeleton is living tissue that is either growing or being renewed. Our understanding of the pathogenesis of bone disorders has progressed considerably over the past 37 years. A large number of genetic and developmental disorders affect the skeleton. Rare bone diseases account for 5% of all birth defects. The skeletal dysplasias are inherited in an autosomal recessive, autosomal dominant, X-linked recessive, and X-linked dominant, and Y-linked manner.


Sign in / Sign up

Export Citation Format

Share Document